Related references
Note: Only part of the references are listed.Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira-Silva et al.
NATURE (2020)
In memoriam: Gerhard Giebisch, MD, 1927-2020
Peter S. Aronson
KIDNEY INTERNATIONAL (2020)
Immunity, microbiota and kidney disease
Felix Knauf et al.
NATURE REVIEWS NEPHROLOGY (2019)
Enterotypes in the landscape of gut microbial community composition
Paul I. Costea et al.
NATURE MICROBIOLOGY (2018)
Metabolic Induction of Trained Immunity through the Mevalonate Pathway
Siroon Bekkering et al.
CELL (2018)
Quantitative microbiome profiling links gut community variation to microbial load
Doris Vandeputte et al.
NATURE (2017)
Alteration of the gut microbiota in Chinese population with chronic kidney disease
Shuanghong Jiang et al.
SCIENTIFIC REPORTS (2017)
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
Christoph Wanner et al.
KIDNEY INTERNATIONAL (2014)
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
Share Paper
